about
Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometryA comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinomaOutcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry.Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosisAnalysis of synovial fluid in knee joint of osteoarthritis:5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Biomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset.Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry.Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.Comparative analysis of methods for identifying recurrent copy number alterations in cancer.Male breast cancer: an update in diagnosis, treatment and molecular profilingSalivary peptidome profiling for diagnosis of severe early childhood cariesProtein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
P2860
Q28487149-750035FD-12C6-4F85-88A0-398A7064C18DQ28741189-ABB6FF2A-893A-4800-A658-41AB0C3A25BBQ31032368-523E5731-97ED-4AF0-BCE2-6F6DA2109A80Q33587249-5429181D-B725-4B51-8CDD-22254F84969CQ33878585-549553C8-127A-44A4-85A3-C01DF200D5A5Q33893305-47ED980F-DEF5-402E-8CF0-DDD960460150Q33894249-0CE29FCC-3B5D-4AE0-A240-47D0E5D76AC3Q33959602-B7223801-E1A4-46DC-99D1-AC092F37883CQ34020523-0BDB774F-D00C-4A61-B875-01DC083980B0Q34213807-586AEE09-D912-4CF4-AFF0-DB2BBFF9D4FEQ34350615-1071044F-6692-47C2-B759-34073B804077Q34465240-9B0ED067-9FC0-4331-BE08-52B6C9C48BE6Q34534035-7CD39104-50FE-4DEB-8673-E12E7E35E5B9Q35660943-992EAF7C-4140-4A71-94C2-C1E5BD7E112BQ36104460-4F6B5EC8-91DB-4CC5-ACF2-3A442A1E4906Q38410125-0AE0D5A2-01F4-46F3-927B-82BC5149FC0FQ38753775-E238CA4D-C443-4B09-9FF7-9727DB73CC41
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MALDI profiling of human lung cancer subtypes.
@ast
MALDI profiling of human lung cancer subtypes.
@en
MALDI profiling of human lung cancer subtypes.
@nl
type
label
MALDI profiling of human lung cancer subtypes.
@ast
MALDI profiling of human lung cancer subtypes.
@en
MALDI profiling of human lung cancer subtypes.
@nl
prefLabel
MALDI profiling of human lung cancer subtypes.
@ast
MALDI profiling of human lung cancer subtypes.
@en
MALDI profiling of human lung cancer subtypes.
@nl
P2093
P2860
P50
P1433
P1476
MALDI profiling of human lung cancer subtypes
@en
P2093
Emilio Camafeita
Enrique Calvo
Enrique Espinosa
Esther Díaz
Iker Sánchez-Navarro
Manuel González-Barón
Manuel Nistal
Rosario Madero
P2860
P356
10.1371/JOURNAL.PONE.0007731
P407
P577
2009-11-05T00:00:00Z